Australian Clinical Labs Ltd
ASX:ACL
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Australian Clinical Labs Ltd
Australian Clinical Labs Ltd
Other Long-Term Assets
Australian Clinical Labs Ltd
Other Long-Term Assets Peer Comparison
HLA
SHL
IDX
CAJ
Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors
| Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Australian Clinical Labs Ltd
ASX:ACL
|
Other Long-Term Assets
AU$8.2m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Healthia Ltd
ASX:HLA
|
Other Long-Term Assets
AU$6.8m
|
CAGR 3-Years
33%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
|
Sonic Healthcare Ltd
ASX:SHL
|
Other Long-Term Assets
AU$68.5m
|
CAGR 3-Years
1%
|
CAGR 5-Years
16%
|
CAGR 10-Years
9%
|
|
|
Integral Diagnostics Ltd
ASX:IDX
|
Other Long-Term Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Capitol Health Ltd
ASX:CAJ
|
Other Long-Term Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
H
|
Healius Ltd
ASX:HLS
|
Other Long-Term Assets
AU$83.7m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
21%
|
See Also
What is Australian Clinical Labs Ltd's Other Long-Term Assets?
Other Long-Term Assets
8.2m
AUD
Based on the financial report for Jun 30, 2023, Australian Clinical Labs Ltd's Other Long-Term Assets amounts to 8.2m AUD.
What is Australian Clinical Labs Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
-5%
Over the last year, the Other Long-Term Assets growth was -13%. The average annual Other Long-Term Assets growth rates for Australian Clinical Labs Ltd have been -29% over the past three years , -5% over the past five years .
You don't have any saved screeners yet
